Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Biomarkers for Early Detection and Prognosis of Heart Failure
Author(s): Moza A Alzaabi , Amin Abdelsalam , Majid Alhammadi , et al Added: 1 year ago

Heart Failure
Biomarkers for Congestion in Heart Failure
Author(s): Antonio Luca Maria Parlati , Cristina Madaudo , Vincenzo Nuzzi , et al Added: 1 year ago

Heart Failure
Early SGLT2i/MRA Use Benefits Suspected HF Patients
Added: 1 week ago Source:  Cardiac Failure Review Journal
Delays in diagnosis and treatment for patients with suspected heart failure (HF) in the community can lead to preventable hospitalisations and deaths. A new modelling study by Dr Kieran Docherty and colleagues suggests that early initiation of disease-modifying therapies in select patients at the time of an elevated natriuretic peptide test could significantly reduce these adverse outcomes… View more

Intervention

Heart Failure
Advances in Congestion Assessment in Decompensated Heart Failure
Author(s): Archana Ganapathy , Jason N Dungu , Anthony D Dimarco , et al Added: 3 weeks ago

Heart Failure
Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches
Author(s): Giulia Tamburrini , Celia de Cobos García , Teresa López Fernández Added: 6 months ago

CV Disease in Special Populations

Heart Failure
The Art and Science of Congestion Diagnosis and Management in Heart Failure
Author(s): Josip A Borovac , Dino Miric Added: 2 months ago

Heart Failure
Job title: Consultant Cardiologist
Dr Henry J Dargie is Consultant Cardiologist at Western Infirmary, Glasgow, and Director of the National Advanced Heart Failure Service, Glasgow (1980-2010) Research Achievements Metolozone in renal failure and heart failure Total Body Potassium in heart and renal failure Early work on role of SNS in hypertension Early RCT work on role of captopril in HF LVH and ventricular arrhythmias… View more
Optimized Pacing Eases oHCM Symptoms in EMORI-HCM Trial
Added: 1 month ago Source:  Radcliffe Cardiology
For patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), the net effect of right ventricular pacing (RVP) has been variable, as it can reduce the left ventricular outflow tract gradient (LVOTg) but may also decrease cardiac output.¹ The EMORI-HCM trial investigated whether electromechanically optimising the atrio-ventricular delay (AVD) could allow RVP to achieve a consistent… View more

Electrophysiology & Arrhythmia

Heart Failure
Understanding the Role of GLP-1 RAs in the Treatment of HF
Author(s): Giovanni Battista Bonfioli , Matteo Pagnesi , Daniela Tomasoni , et al Added: 6 months ago

Cardiovascular Renal Metabolic
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type
Author(s): Marianna Fontana Added: 9 months ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,… View more

Heart Failure